Envestnet Asset Management’s Imunon IMNN Stock Holding History

Envestnet Asset Management’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-128	Closed	-$93K	–	3134
2020 Q2	$93K	Buy	+128	New	+$55.5K	﹤0.01%	2988

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Envestnet Asset Management's IMNN Position: Q3 2020 in Review

Envestnet Asset Management sold out of Imunon (IMNN) in Q3 2020, closing a stake of 128 shares — an estimated $93K sold.

Envestnet Asset Management first reported a position in IMNN in Q2 2020 and held it in 1 quarter. The position peaked at $93K in Q2 2020. 34 funds tracked by Wall St. Rank hold IMNN as of Q3 2020.

Envestnet Asset Management reported no remaining Imunon position as of Q3 2020 after selling out during the quarter.
Envestnet Asset Management sold 128 Imunon shares in Q3 2020, an estimated $93K.
Envestnet Asset Management first reported a position in Imunon in Q2 2020 and held it in 1 quarter.
Envestnet Asset Management's Imunon position peaked at $93K in Q2 2020.
34 funds tracked by Wall St. Rank held Imunon as of Q3 2020.

Based on Envestnet Asset Management's 13F filing for Q3 2020, filed 9 Oct 2020.